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ABSTRACT
Background Surveillance of sepsis incidence is 
important for directing resources and evaluating 
quality- of- care interventions. The aim was to develop and 
validate a fully- automated Sepsis-3 based surveillance 
system in non- intensive care wards using electronic 
health record (EHR) data, and demonstrate utility by 
determining the burden of hospital- onset sepsis and 
variations between wards.
Methods A rule- based algorithm was developed using 
EHR data from a cohort of all adult patients admitted at 
an academic centre between July 2012 and December 
2013. Time in intensive care units was censored. To 
validate algorithm performance, a stratified random 
sample of 1000 hospital admissions (674 with and 326 
without suspected infection) was classified according 
to the Sepsis-3 clinical criteria (suspected infection 
defined as having any culture taken and at least two 
doses of antimicrobials administered, and an increase 
in Sequential Organ Failure Assessment (SOFA) score by 
>2 points) and the likelihood of infection by physician 
medical record review.
Results In total 82 653 hospital admissions were 
included. The Sepsis-3 clinical criteria determined by 
physician review were met in 343 of 1000 episodes. 
Among them, 313 (91%) had possible, probable or 
definite infection. Based on this reference, the algorithm 
achieved sensitivity 0.887 (95% CI: 0.799 to 0.964), 
specificity 0.985 (95% CI: 0.978 to 0.991), positive 
predictive value 0.881 (95% CI: 0.833 to 0.926) and 
negative predictive value 0.986 (95% CI: 0.973 to 
0.996). When applied to the total cohort taking into 
account the sampling proportions of those with and 
without suspected infection, the algorithm identified 
8599 (10.4%) sepsis episodes. The burden of hospital- 
onset sepsis (>48 hour after admission) and related 
in- hospital mortality varied between wards.
Conclusions A fully- automated Sepsis-3 based 
surveillance algorithm using EHR data performed well 
compared with physician medical record review in non- 
intensive care wards, and exposed variations in hospital- 
onset sepsis incidence between wards.
InTRoduCTIon
Sepsis, a severe organ dysfunction 
induced by infection, is a leading cause of 
morbidity and death worldwide.1–3 The 
true burden of sepsis has been difficult 
to assess, mainly due to the absence of a 
generalisable gold standard. About one 
third of sepsis episodes are considered 
healthcare- associated and the problem of 
sepsis needs to be addressed as a patient 
safety concern.4
Surveillance with feedback to health-
care personnel and policy makers is the 
backbone of most quality improvement 
programmes for healthcare- associated 
infections.5 To be useful, such surveil-
lance systems require standardised 
case- definitions free from subjective 
interpretations and appropriate denom-
inator data.6 Surveillance systems based 
on clinical data are preferred to admin-
istrative data, as these are more objec-
tive, reproducible and stable over time.7 8 
Fully- automated surveillance systems with 
data from electronic health records 
(EHR) could replace surveillance relying 
on manual chart review and generate 
continuous data from large populations, 
but needs thorough validation before 
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implementation.5 As mandatory reporting of sepsis 
is becoming increasingly common, defining a surveil-
lance method that produces objective high quality 
data is important.9 Reliable sepsis surveillance data 
can benefit large patient groups by allowing clin-
ical resources to be directed to where they are most 
needed. Continuous incidence monitoring can also be 
used to evaluate quality of care interventions down to 
the ward level, and for benchmarking sepsis prediction 
models and artificial intelligence tools integrated with 
the EHR.8 10 11
In 2016 the Third International Consensus Defini-
tion for Sepsis and Septic Shock (Sepsis-3) was intro-
duced.12 13 An advantage of the new definition (here 
denoted Sepsis-3 clinical criteria) lies in its objective 
case- definition, which requires that the patient has a 
suspected infection in combination with a newly devel-
oped organ dysfunction.13 Yet, the performance of an 
automated surveillance system using these criteria has 
not been evaluated. In 2018, the Center of Disease 
Control and Prevention (CDC) presented an addi-
tional sepsis definition called Adult Sepsis Event (ASE) 
aimed specifically for surveillance purposes.14 The ASE 
differs from the Sepsis-3 clinical criteria with regards 
to both classifications of suspected infection and organ 
dysfunction. The focus of ASE is on patients with more 
severe disease, with more than half of cases admitted 
to the intensive care unit (ICU), and it has been shown 
to underestimate the burden of sepsis cases defined by 
Sepsis-3 criteria.15
The primary aim of this study was to develop and 
validate a fully- automated EHR- based surveillance 
algorithm against physician medical record review in 
non- intensive care wards using the Sepsis-3 clinical 
criteria. A secondary aim was to demonstrate the algo-
rithm’s utility by determining the burden of hospital- 
onset sepsis in a general hospital population.
MeThodS
design, data source and study population
This was an observational study performed at an 
academic centre with 1350 beds divided between two 
hospitals and serving a population of 2.3 million inhab-
itants. Data was obtained from routinely prospec-
tively entered information in the EHR system, stored 
in a research databank called Health Bank—Swedish 
Health Record Research Infrastructure.16 The data-
base structure is a duplicate of the operating EHR 
system, where each subject can be followed over time, 
and consists of all medical records from more than 
2 million anonymised patients that received care at the 
hospital between 2006 and 2013. Due to improved 
recording in the EHR during the later years, analyses 
were restricted to July 2012 until December 2013, 
except for information about International Classifica-
tion of Diseases (ICD) codes that were used to estimate 
the presence of co- morbidities in patients, which were 
retrieved up to 5 years before inclusion. Data collection 
included demographics, hospital administrative data, 
vital parameters, laboratory findings, microbiological 
data, medications and in- hospital mortality.
Patients >18 years admitted to the hospital for 
>24 hours were included, and followed until first sepsis 
episode, discharge or death. Patients were excluded if 
admitted to an obstetric ward and censored during 
ICU- care, due to lack of data on vital parameters and 
medication for these wards.
Sepsis-3 surveillance case definition
The rule- based algorithm was based on the oper-
ational Sepsis-3 clinical criteria: a suspected infec-
tion in combination with an increase in Sequential 
Organ Failure Assessment (SOFA) score by >2 points 
compared with the baseline.13
Suspected infection was defined as having any 
culture taken and at least two doses of antimicrobials 
administered. If the patient was admitted to the ICU 
prior to 24 hours, or died prior to 48 hours from the 
first dose of antimicrobials, they were deemed to have 
a suspected infection despite only being given one 
dose. Cultures had to be performed within 24 hours 
after the start of antimicrobial treatment. Antimicro-
bial treatment had to be started within 72 hours after 
culture. Onset of infection was determined based on 
which of these events occurred first.13 Sensitivity anal-
yses were done using different definitions of suspected 
infections: only blood cultures and two doses of anti-
microbials, any culture and four calendar days of anti-
microbials or only blood cultures and four calendar 
days of antimicrobials, of which the last being equiv-
alent to the ASE definition (online supplementary 
methods 1).14
Organ dysfunction was measured as the maximum 
SOFA score 48 hours before to 24 hours after onset of 
infection and compared with a baseline SOFA score 
measured separately (online supplementary methods 
1 and online supplementary figure 1). Similar to the 
study that developed the Sepsis-3 clinical criteria, 
missing values during the 72 hours window were 
considered to be normal.13 Since we studied a non- 
ICU population, some modification to the SOFA score 
was done. The most important changes were, (i) if 
PaO2 was not available it was calculated from periph-
eral capillary oxygen saturation (SpO2), (ii) if Glasgow 
Coma Scale (GCS) was not available, structured data 
on ‘alert’ (interpreted as GCS score 15 points) or ‘not 
alert’ (interpreted as GCS score 14 points) was used, 
and (iii) urine output was not used due to data being 
unavailable. For each component of the SOFA score, 
the baseline was defined as the latest value measured 
before the 72 hours time window, and was assumed to 
be zero in patients not known to have a pre- existing 
organ dysfunction. Pre- existing organ dysfunction was 
based on measured parameters (coagulation, liver, renal 
and respiration) within the previous three months or 
a specific ICD- code (chronic dialysis or home oxygen 
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therapy) within the last year. For SOFA cardiovascular 
and central nervous system (CNS) scores, only values 
measured during the current hospital episode was 
used. Onset of sepsis was when the patient fulfilled the 
organ dysfunction criteria.
To capture the burden of healthcare- associated 
sepsis, hospital- onset (HO) sepsis was defined as 
onset of suspected infection and organ dysfunction 
48 hours after admission, or re- admission with sepsis 
within 48 hours of discharge. All other episodes were 
defined as community- onset (CO) sepsis. A patient 
could have several suspected infections, but only the 
first episode of sepsis was considered for each hospital 
episode. Algorithm classification based on clinical data 
was compared with classification using the following 
ICD-10 codes indicating sepsis: A02.1, A22.7, A26.7, 
A32.7, A39.2, A39.4, A40.x, A41.x, A42.7, A48.3, 
B37.7, M72.6, R57.2, R65.1 and R65.9.
Validation using medical record review
To evaluate the performance of the surveillance algo-
rithm, two validation sets including a total of 1000 
hospital admissions were selected from the entire 
hospital cohort for medical record review. In the first 
validation set, 674 hospital admissions were randomly 
sampled from patients with suspected infection (540 
CO and 134 HO episodes). Medical records including 
demographics, hospital administrative data, free text 
notes, medications, microbiological cultures, labo-
ratory and radiological findings were reviewed by 
two trained infectious diseases physicians to clas-
sify whether the patient fulfilled the Sepsis-3 clinical 
criteria. The first 10 patients were reviewed together as 
a run- in period, and further reviewing was performed 
independently with an overlap of 100 patients. There 
was substantial agreement between reviewers, with 
Cohen’s kappa 0.75 for sepsis classification. Compli-
cated cases were classified using a consensus decision. 
The reviewers were blinded from the results of the 
developed surveillance algorithm. In the second vali-
dation set, 326 episodes were randomly sampled from 
hospital admissions without a suspected infection. Full 
medical records were assessed by one of the reviewers 
and classified according to the Sepsis-3 clinical criteria.
The medical records of subjects that fulfilled the 
Sepsis-3 clinical criteria by physician review were 
assessed in further detail for likelihood and source 
of infection. The categorisation followed previously 
validated criteria based on CDC and The Interna-
tional Sepsis Forum definitions.17–20 Accordingly, 
episodes were divided by source and classified on a 
four- graded scale as no infection, possible infection, 
probable infection and definite infection. For details 
regarding the exact definitions used we refer to a 
previously published study by Klein Klouwenberg et 
al.18 One minor modification to the criteria was done 
in this study. We added unknown source, defined as 
patients (i) with symptoms of an infection, (ii) the 
symptoms indicated an infection according to the 
attending physician, and (iii) the patient received a full 
course of anti- infective treatment, but (iv) no source 
could be determined. Unknown source could only be 
classified as possible infection. In the assessment of the 
sensitivity and specificity of the surveillance algorithm, 
patients had to fulfil both the Sepsis-3 clinical criteria 
and the possible, probable or definite infection criteria 
to be classified as true sepsis.
Statistical analyses
To assess algorithm performance in the intended target 
population of all patients admitted to the hospital, 
sensitivity, specificity, positive predictive value (PPV) 
and negative predictive value (NPV) were calculated 
by generalising the proportions from validation to 
the entire cohort, as previously described by Rhee et 
al.15 CI for sensitivity, specificity, PPV and NPV were 
calculated as the 2.5th and 97.5th percentiles of point 
estimates obtained from 10 000 bootstrap samples for 
each of the two validation sets (n=674 and n=326) 
using the ‘boot’ package of R. To account for uncer-
tainty, the bootstrapping was performed before extrap-
olating the proportions from validation to the entire 
hospital cohort. The extrapolation accounted for the 
nested selection of suspected CO and HO infections, 
as well as for the proportion of sepsis cases from the 
population of patients who did not have a suspected 
infection episode. In sensitivity analyses of different 
definitions of suspected infection, the proportion of 
patients that were falsely categorised as true negatives 
due to not fulfilling the tested suspected infection defi-
nition was also accounted for. When assessing algo-
rithm performance for CO infections, HO infections 
were omitted and vice versa.
CIs for incidence densities of CO sepsis per 100 
admissions and HO sepsis per 1000 patient days at 
risk were calculated using the R package ‘compeir’, 
assuming a log- normal distribution. Cumulative inci-
dence function (CIF) for the probability of HO sepsis 
was calculated using the Aalen- Johansen estimator 
and taking into account competing risks: ICU admis-
sion, discharge or death.21 Pairwise comparison of CIF 
between wards was calculated using the R package 
‘cmprsk’, which is based on the Fine and Gray (1999) 
formula.22 Cumulative incidence regression analysis 
for in- hospital death stratified by likelihood of infec-
tion (none- possible vs probable- definite) was deter-
mined with discharge as a competing event using the 
‘stcrreg’ command in STATA. Confounders associated 
with both the likelihood of infection and in- hospital 
death were considered using a directed acyclic graph 
based on a priori clinical expertise and available liter-
ature. Accordingly, adjustments were made for age, 
Charlson comorbidity index and CO/HO onset, but 
not for severity of disease since this covariate could be 
on the causal pathway between likelihood of infection 
and in- hospital death.
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Results are presented as median (med) and IQR 
or numbers (No.) and percentages as appropriate. 
Differences between categorical variables and between 
continuous variables were assessed using the Fisher 
exact and Mann- Whitney U tests, respectively. Missing 
data was not considered missing at random, but rather 
owing to clinical decisions. Based on the assumption 
that data would still be not missing at random even 
after controlling for other observed variables, we did 
not perform multiple imputation for individual SOFA 
score variables. Data handling and automated sepsis 
annotation was performed in Python V.3.6. Statistical 
analyses were done in R V.3.4.3 and STATA V.14.2.
ReSulTS
In total 144 179 hospital admissions of 99 864 patients 
were recorded during the study period, of which 95 
858 admissions fulfilled the inclusion criteria (patients 
>18 years admitted to the hospital for >24 hours). 
Twelve thousand nine hundred- fifty admissions to the 
obstetrical wards, 214 admissions to paediatric wards 
and 41 direct transfers between hospital ICUs were 
excluded. Finally, a total of 82 653 hospital admis-
sions of 54 884 patients were included in the analysis. 
There was a suspected infection in 19 479 (23.6%) 
of the admissions and no suspected infection in 63 
174 (76.4%) of the admissions. The median patient 
age was 64 years, 50.9% were women and the median 
length of stay was 3.8 days.
Validation of the surveillance case definition
In total, 340 of 674 patients with suspected infection 
(50.4%) and three of 326 without suspected infection 
(0.9%) fulfilled Sepsis-3 criteria according to physician 
medical record review (table 1). Among subjects that 
fulfilled Sepsis-3 criteria, 109/343 (31.8%) fulfilled 
the criteria for possible infection, 87/343 (25.4%) for 
probable infection, and 117/343 (34.1%) for definite 
infection. In total, 30/343 (8.7%) were classified as no 
infection. Hence, 311 of 674 patients (46.1%) with 
suspected infection and two of 326 patients (0.6%) 
without suspected infection were finally considered 
as true sepsis by reviewers. In subjects with suspected 
infection, the algorithm classified 288 true positive, 39 
false positive, 324 true negative and 23 false negative 
sepsis cases. In subjects without suspected infection, 
the algorithm classified zero sepsis cases resulting in 
324 true negative and two false negative cases. Based 
on the medical record reviewed reference, the algo-
rithm achieved sensitivity 0.887 (95% CI: 0.799 to 
0.964), specificity 0.985 (95% CI: 0.978 to 0.991), 
PPV 0.881 (95% CI: 0.833 to 0.926) and NPV 0.986 
(95% CI: 0.973 to 0.996) when extrapolating propor-
tions to the entire hospital cohort (table 2). When 
assessed only in subjects with suspected infection, the 
algorithm achieved sensitivity 0.926 (95% CI: 0.896 
to 0.955), specificity 0.893 (95% CI: 0.859 to 0.923), 
PPV 0.881 (95% CI: 0.833 to 0.926) and NPV 0.934 
(95% CI: 0.895 to 0.969) (table 2). The most common 
reasons for misclassification resulting in reduced sensi-
tivity was respiratory or CNS dysfunction only being 
mentioned in free text, followed by overestimation 
of pre- existing organ dysfunction or development 
of infection related organ dysfunction outside of the 
72 hours time window (online supplementary table 1). 
Reasons for imperfect specificity was due to episodes 
judged by reviewers as no infection, misclassification 
of baseline SOFA score or obvious measurement errors 
of vital parameters in the EHR.
For CO- sepsis the algorithm achieved sensitivity 
0.910 (95% CI: 0.825 to 0.984), specificity 0.987 
(95% CI: 0.982 to 0.991), PPV 0.881 (95% CI: 0.844 
to 0.917) and NPV 0.990 (95% CI: 0.980 to 0.998). 
For HO- sepsis the algorithm achieved sensitivity 0.794 
(95% CI: 0.683 to 0.889), specificity 0.997 (95% CI: 
0.995 to 0.999), PPV 0.877 (95% CI: 0.782 to 0.966) 
and NPV 0.994 (95% CI: 0.991 to 0.997). Restricting 
analyses to hospital admissions without ICU admission 
(n=78 318) resulted in slightly decreased sensitivity 
0.879 (0.793–0.952) but increased specificity 0.988 
(0.983–0.992) and PPV 0.895 (0.860–0.931). For 
hospital admissions with ICU admission (n=4335), 
sensitivity was higher 0.952 (0.881–1.000) at the 
expense of decreased specificity 0.938 (0.907–0.969) 
and PPV 0.800 (0.712–0.894) (online supplementary 
table 2).
Classification of infection as probable or definite was 
not associated with a significantly different in- hospital 
mortality compared with subjects with no or possible 
infection (online supplementary figure 2). The most 
common source of infection in true sepsis patients was 
respiratory (n=119/313, 38.0%), followed by urogen-
ital (n=54/313, 17.3%), unknown source (n=42/313, 
13.4%), bloodstream (35/313, 11.2%), skin, bone and 
joint (30/313, 9.6%), abdominal (n=26/313, 8.3%) 
and other infectious sources (7/313, 2.2%) (table 1 
and online supplementary figure 3). Among patients 
classified as having an unknown source of infection, 
15/42 (35.7%) had neutropenia.
The burden of sepsis
The surveillance algorithm identified 8599 sepsis 
episodes (10.4% of all hospital admissions), of which 
7493 (87.1%) were CO sepsis and 1106 (12.9%) were 
HO sepsis (table 3). The most common SOFA score trig-
gers for sepsis were respiratory and renal dysfunction 
(online supplementary figure 4). Availability of data to 
calculate SOFA score during suspected infection ranged 
between 92.0%–95.0% (coagulation, renal, respira-
tory and cardiovascular) and 38.3%–55.0% (liver and 
CNS) for community- onset episodes, compared with 
73.2%–86.2% (coagulation, respiratory, renal and 
cardiovascular) and 3.0%–30.2% (CNS and liver) for 
hospital- onset episodes (online supplementary table 
3). Assumptions of normal baseline SOFA score were 
almost exclusively done in community- onset episodes 
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Table 1 Characteristics of patients fulfilling Sepsis-3 clinical criteria* according to physician review of medical records
All
Likelihood of infection
None Possible Probable Definite
Patients, No. (% of all) 343 (100.0) 30 (8.7) 109 (31.8) 87 (25.4) 117 (34.1)
Female sex, No. (%) 158 (46.1) 13 (43.3) 43 (39.4) 34 (39.1) 68 (58.1)
Age, med (IQR) 71 (60–81) 68 (52–81) 70 (60–79) 72 (60–83) 72 (62–81)
Length of stay, med (IQR) 11 (6–20) 10 (6–14) 10 (6–19) 11 (5–24) 12 (7–22)
Charlson Comorbidity Index†, med (IQR) 2 (0–3) 1 (0–2) 2 (1–3) 1 (0–2) 2 (0–3)
Risk factors at sepsis onset
Prior surgery (30 days)‡, No. (%) 82 (23.9) 6 (20.0) 32 (29.4) 11 (12.6) 33 (28.2)
Central venous catheter, No.(%) 87 (25.4) 8 (26.7) 33 (30.3) 13 (14.9) 33 (28.2)
Urinary catheter, No. (%) 80 (23.4) 11 (36.7) 28 (25.7) 18 (20.7) 23 (19.7)
Sepsis characteristic
Community- onset sepsis§, No. (%) 277 (80.8) 27 (90.0) 78 (71.6) 77 (88.5) 95 (81.2)
Hospital- onset sepsis§, No. (%) 66 (19.2) 3 (10.0) 31 (28.4) 10 (11.5) 22 (18.8)
ICU admission¶, No. (%) 52 (15.2) 10 (33.3) 14 (12.8) 9 (10.3) 19 (16.2)
SOFA baseline, med (IQR) 0 (0–1) 0(0) 0 (0–1) 0 (0–1) 0 (0–1)
SOFA Max, med (IQR) 4(2–5) 3(2–4) 3(2–4) 4(2–5) 4(3–5)
Shock**, No. (%) 30 (8.7) 0 (0) 10 (9.2) 7 (8.0) 13 (11.1)
Neutropenia††, No. (%) 46 (13.4) 2 (6.7) 19 (17.4) 9 (10.3) 16 (13.7)
Bloodstream infection,‡‡ No. (%) 65 (19.0) 0 (0) 2 (1.8) 7 (8.0) 56 (47.9)
Complete course of antimicrobials, No. (%) 317 (92.4) 12 (40.0) 105 (96.3) 85 (97.7) 115 (98.3)
Source of infection
Respiratory infection, No. (%) 119 (34.7) 0 (0) 45 (41.3) 58 (66.7) 16 (13.7)
Urogenital infection, No. (%) 54 (15.7) 0 (0) 9 (8.3) 20 (23.0) 25 (21.4)
Unknown source, No. (%) 42 (12.2) 0 (0) 42 (38.5) 0 (0) 0 (0)
Bloodstream infection, No. (%) 35 (10.2) 0 (0) 0 (0) 1 (1.1) 34 (29.1)
Skin, bone and joint infection, No. (%) 30 (8.7) 0 (0) 4 (3.7) 0 (0) 26 (22.2)
Abdominal, No. (%) 26 (7.6) 0 (0) 7 (6.4) 6 (6.9) 13 (11.1)
Other infection, No. (%) 7 (2.0) 0 (0) 2 (1.8) 2 (2.3) 3 (2.6)
In- hospital mortality, No. (%) 40 (11.6) 1 (3.3) 16 (14.7) 13 (14.9) 10 (8.5)
ICD-10 code for sepsis,§§ No. (%) 59 (17.2) 1 (3.3) 4 (3.7) 13 (14.9) 41 (35.0)
*Sepsis-3 defined as any culture taken and administration of two doses antimicrobials combined with change in SOFA score of two points or more during 
48 hours before and 24 hours after onset of infection compared with baseline SOFA score calculated before this time window.
†Weighted Charlson comorbidity index.50 Total modified Charlson score: 0–24.
‡Prior surgery was generated using procedure codes. Time zero was sepsis onset.
§Hospital- onset defined as an episode 48 hours after admission or if the patient was readmitted with sepsis within 48 hours of discharge. All other 
episodes were defined as community- onset.
¶ICU admission at any time during hospitalisation.
**Shock defined as patients receiving vasopressors.
††Neutropenia defined as absolute neutrophil count less than 0.5x109/L.
‡‡Bloodstream infection at any time during hospitalisation (online supplement methods 2).
§§International Classification of Diseases (ICD)-10 codes including A02.1, A22.7, A26.7, A32.7, A39.2, A39.4, A40.x, A41.x, A42.7, A48.3, B37.7, M72.6, 
R57.2, R65.1 and R65.9.
ICU, intensive care unit; med, median; SOFA, Sequential Organ Failure Assessment.
(range between 20.2%–46.8% for liver, renal, coagu-
lation and respiration), but a large portion of patients 
had a measured baseline value (range between 18.1%–
56.0% for liver, respiration, coagulation and renal) 
(online supplementary table 4). In hospital- onset 
suspected infection, only 0.4%–3.2% (all SOFA score 
components) had an assumed normal baseline value.
Only 13.4% of sepsis episodes had an ICD-10 code 
indicating sepsis. The in- hospital mortality was 8.6% 
for all sepsis episodes, 8.0% for CO sepsis and 12.7% 
for HO- sepsis, compared with 2.4% in the entire 
hospital cohort. The incidence was 9.1 (95% CI: 8.9 
to 9.3) per 100 admissions for CO sepsis and 2.6 (95% 
CI: 2.4 to 2.8) per 1000 patient days for HO sepsis, 
with a CIF of 0.013 at day 30 for HO sepsis in the 
competing risk model (online supplementary figure 5). 
The cumulative incidence of HO sepsis varied signifi-
cantly depending on type of hospital ward, with the 
highest risk in Transplant (CIF=0.078) and Haema-
tology (CIF=0.061) wards, and the lowest risk in 
Orthopaedic (CIF=0.004) wards (figure 1 and online 
supplement figures 6 and 7). In- hospital mortality 
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after HO sepsis was highest in internal medicine wards 
(17.3%) compared with only 2.1% in thoracic surgery 
wards (online supplementary table 5).
Sensitivity analysis demonstrating variations in 
number of sepsis episodes and in- hospital mortality 
using different definitions of suspected infection are 
shown in figure 2. Mortality in sepsis episodes fulfilling 
only the definition used in the Sepsis-3 clinical criteria 
(any culture and two doses of antimicrobials), but not 
the definition used in the ASE (blood cultures and four 
days of antimicrobials), was 8.4% (n=174/2066). This 
was not significantly different from mortality 8.6% 
(n=563/6533) in sepsis episodes fulfilling both defini-
tions (p=0.78 for difference).
dISCuSSIon
In this study, we show that it is possible to build a fully- 
automated sepsis surveillance system based on the 
Sepsis-3 clinical criteria that correctly captures almost 
90% of sepsis episodes occurring outside the ICU and 
assigns the events to space (ward) and time (onset). 
The mortality and patient characteristics in our study 
were similar to the studies used when developing the 
Sepsis-3 definition, speaking in favour of our results 
being generalisable to the European and US setting.13 
The usefulness of the algorithm was shown by indi-
cating variations in HO sepsis incidence and mortality 
depending on ward type, which can be used to inform 
infection prevention interventions and improve sepsis 
care.
The sepsis definition is based on the pathophysiolog-
ical response to an infection and is neither constrained 
to a certain type of infection nor does it require 
that the infection is microbiologically confirmed.12 
Quality improvement initiatives focusing on educa-
tion and sepsis care bundles have been associated with 
survival benefits, warranting structured approaches in 
sepsis care.23 24 In our study, the majority of patients 
presented with sepsis on admission, but the burden 
of HO sepsis was still substantial. Recent data have 
associated HO sepsis with mortality approximately 
twice as high compared with CO sepsis.25 Despite this, 
traditional surveillance programmes for healthcare- 
associated infections, such as CDC/National Health-
care Safety Network and European Centre for Disease 
Prevention and Control, do not include sepsis as a 
distinct entity.19 26 27
Initiatives to monitor sepsis incidence have often 
focussed on using administrative hospital data, such as 
discharge diagnosis, trigger based audits or reporting to 
clinical databases, all carrying risk of bias and making 
comparisons between hospitals difficult.28–30 The use 
of ICD- codes for sepsis surveillance is associated with 
considerable uncertainty31 32 and studies indicate that 
some of the increased incidence of sepsis during the 
last decade can be explained by changes in coding prac-
tices.33–37 Overall, epidemiological surveillance based 
on explicit sepsis ICD- codes seems to underestimate 
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Table 3 Characteristics of fully- automated sepsis incidence surveillance in a general hospital population
All No sepsis
Sepsis-3
clinical criteria
Community- onset* 
Sepsis-3 clinical 
criteria
Hospital- onset* 
Sepsis-3 clinical 
criteria
Hospital admissions, No. 82 653 74 054 8599 7493 1106
Patients, No. 54 884 51 343 7286 6472 1055
Female sex, No. (%) 27 928 (50.9) 26 378 (51.4) 3213 (43.9) 2876 (44.2) 430 (41.4)
Age, med (IQR) 64.0 (47.0–75.0) 63.0 (47.0–74.0) 70.0 (59.0–80.0) 70.0 (60.0–81.0) 67.0 (54.0–76.0)
Length of stay, med (IQR) 3.8 (2.0–7.6) 3.3 (1.9–6.9) 8.0 (4.2–15.7) 7.0 (4.0–12.6) 23.0 (14.7–36.7)
Charlson Comorbidity 
Index†, med (IQR)
0 (0–2) 0 (0–2) 2 (0–3) 2 (0–2) 2 (0–3)
Comorbidities‡, No. (%)
Chronic pulmonary disease 2370 (4.3) 2103 (4.1) 692 (9.5) 645 (10.0) 76 (7.2)
Cancer 14 036 (25.6) 13 094 (25.5) 2601 (35.7) 2240 (34.6) 514 (48.7)
Cerebral vascular disease 4061 (7.4) 3783 (7.4) 670 (9.2) 580 (9.0) 123 (11.7)
Chronic heart failure 2887 (5.3) 2643 (5.1) 792 (10.9) 708 (10.9) 113 (10.7)
Myocardial infarction 2638 (4.8) 2485 (4.8) 403 (5.5) 361 (5.6) 49 (4.6)
Connective tissue disease 1471 (2.7) 1360 (2.6) 287 (3.9) 259 (4.0) 42 (4.0)
Diabetes mellitus 1681 (3.1) 1541 (3.0) 442 (6.1) 394 (6.1) 65 (6.2)
HIV infection 54 (0.1) 46 (0.1) 18 (0.2) 17 (0.3) 2 (0.2)
Kidney disease 2222 (4.0) 1998 (3.9) 644 (8.8) 565 (8.7) 111 (10.5)
Liver disease 1281 (2.3) 1173 (2.3) 340 (4.7) 294 (4.5) 62 (5.9)
Prior surgery (30 days)§, 
No. (%)
12 274 (14.9) 10 091 (13.6) 2186 (25.4) 1458 (19.5) 728 (65.8)
Suspected infection¶, No. 
(%)
19 479 (23.6) 10 880 (14.7) 8599 (100.0) 7493 (100.0) 1106 (100.0)
Sepsis**, No. (%)
Sepsis-3 clinical criteria 8599 (10.4) 0 (0.0) 8599 (100.0) 7493 (100.0) 1106 (100.0)
ICD-10 coded 2055 (2.5) 907 (1.2) 1148 (13.4) 939 (12.5) 209 (18.9)
Community- onset sepsis, 
No. (%)
7493 (9.1) 0 (0.0) 7493 (87.1) 7493 (100.0) 0 (0.0)
Hospital- onset sepsis, No. 
(%)
1106 (1.3) 0 (0.0) 1106 (12.9) 0 (0.0) 1106 (100.0)
ICU admission††, No. (%) 4335 (5.2) 3471 (4.7) 864 (10.0) 578 (7.7) 286 (25.9)
ICU days, med (IQR) 1.4 (0.9–4.1) 1.2 (0.9–3.5) 2.8 (1.1–6.3) 2.1 (1.0–4.6) 4.8 (2.0–11.4)
Bloodstream infection‡‡, 
No. (%)
2659 (3.2) 1104 (1.5) 1555 (18.1) 1279 (17.1) 276 (25.0)
In- hospital mortality, No. 
(%)
1953 (2.4) 1216 (1.6) 737 (8.6) 596 (8.0) 141 (12.7)
*Hospital- onset defined as a sepsis episode 48 hours after admission or if the patient was readmitted with sepsis within 48 hours of discharge. All other 
sepsis episodes were defined as community- onset.
†Weighted Charlson comorbidity index.50 Total modified Charlson score: 0–24.
‡Comorbidity defined according to International Classification of Diseases (ICD)-10 codes registered within five years prior to hospitalisation.51
§Prior surgery was generated using procedure codes. For sepsis patients time zero was sepsis onset. For non- sepsis patients time zero was admission.
¶Defined as any culture taken and administration of two doses antimicrobials.
**Sepsis-3 defined as suspected infection combined with change in SOFA score of two points or more. ICD-10 codes including A02.1, A22.7, A26.7, 
A32.7, A39.2, A39.4, A40.x, A41.x, A42.7, A48.3, B37.7, M72.6, R57.2, R65.1 and R65.9.
††Intensive care unit admission any time during hospitalisation.
‡‡Bloodstream infection any time during hospitalisation (online supplement methods 2).
ICU, intensive care unit; med, median; SOFA, Sequential Organ Failure Assessment.
the incidence of sepsis compared with using clinical 
data,15 and in our study only 13.4% of sepsis patients 
had an ICD- code indicating sepsis. Similar findings 
have been observed in studies comparing medical 
record review to ICD- codes,38 39 but manual medical 
record review is both resource intensive and associated 
with subjectivity and limited inter- rater agreement.40 41 
Recently, a case definition, ASE, was developed by 
CDC to facilitate automated sepsis surveillance using 
clinical data from EHR.14 Compared with Sepsis-3, the 
ASE algorithm is based on different criteria for both 
suspected infection and organ dysfunction and tends 
to capture a patient population with higher mortality 
than the Sepsis-3 criteria.15 The sensitivity and spec-
ificity of the ASE definition, when using Sepsis-3 as 
the reference standard, was 69.7% and 98.1% in a US 
copyright.
 on July 21, 2020 at A
alborg U
niversity Library. P
rotected by
http://qualitysafety.bm
j.com
/
B
M
J Q
ual S
af: first published as 10.1136/bm
jqs-2019-010123 on 6 F
ebruary 2020. D
ow
nloaded from
 
8 Valik JK, et al. BMJ Qual Saf 2020;0:1–11. doi:10.1136/bmjqs-2019-010123
Original research
Figure 1 Cumulative incidence function (CIF) curves of hospital- onset 
sepsis stratified by ward type and taking into account competing risks 
ICU- admission, discharge or death. The CIF curves differed significantly in 
pairwise comparison (online supplementary figure 6). ICU, intensive care 
unit.
Figure 2 Effect on number of sepsis episodes and in- hospital mortality 
depending on different definitions of suspected infection. (2A) shows 
number of sepsis episodes per definition of suspected infection. (2B) 
shows in- hospital mortality (%) for sepsis cases per definition of suspected 
infection. ‘Any culture and two doses of antimicrobials’ is equivalent to 
the definition of suspected infection used in the Sepsis-3 clinical criteria. 
only ‘blood cultures and four days of antimicrobials’ is equivalent to the 
definition of suspected infection used in the Adult Sepsis Event (ASE) 
criteria. Note that in some episodes, time of onset of infection differed 
depending on the definition of suspected infection. This affected the time 
window for assessing organ dysfunction, which in a few cases resulted in 
differences in the classification of sepsis.
hospital setting,15 compared with 88.7% and 98.5% 
for our algorithm in a European hospital. Using the 
ASE definition of suspected infection (blood culture 
and four days of antimicrobials) in our cohort resulted 
in 71.8% sensitivity and 99.2% specificity.
In this study, 91% of patients with sepsis according 
to the Sepsis-3 clinical criteria had either a possible, 
probable or definite infection as determined by physi-
cian review of medical records in post- hoc assess-
ment, which is similar to a previous report from the 
ICU.17 This suggests that the Sepsis-3 criteria perform 
well in capturing a patient population where clini-
cians maintain a suspicion of infection also after 
the initial treatment phase. Organ dysfunction in 
the Sepsis-3 clinical criteria is determined by SOFA 
score and concerns have been raised that this is not 
suited for EHR- based surveillance due to the inclu-
sion of parameters not frequently measured in most 
patients.42 However, integration of automated SOFA 
score calculators in EHR systems have shown strong 
agreement with manual score calculations,43 limiting 
the need to use other criteria for organ dysfunctions. 
The SOFA score is based on assessment of six organ 
systems, compared with ASE that assesses five organ 
systems (CNS dysfunction is omitted). For respira-
tory and cardiovascular dysfunction, the ASE requires 
initiation of mechanical ventilation and vasopressor 
treatment. This biases sepsis surveillance towards 
patients eligible for aggressive treatment and access to 
ICU care, limiting generalisability to all hospitalised 
patients. One of the arguments for abandoning the 
Sepsis-3 definition in ASE was to facilitate widespread 
use to hospitals with limited collection of EHR data. 
However, the only additional data used in our surveil-
lance case definition was vital parameters, which are 
routinely collected in many hospitals.
We show that it is feasible to use a surveillance 
algorithm based on the Sepsis-3 clinical criteria to 
automatically identify sepsis with high sensitivity and 
predictive values in non- ICU wards, and thus keeping 
a uniform sepsis definition for EHR surveillance. The 
objective of such surveillance is not early bedside sepsis 
recognition, but rather making continuously collected 
data on disease burden and patient management easily 
available. The possible use- cases of such surveillance 
data are multifaceted. First, incidence data presented 
down to the single- ward level as shown in this study, 
creates important feedback loops, which can guide 
quality improvement interventions, such as educa-
tion programmes, systems for earlier sepsis recogni-
tion, treatment bundles and targeted infection control 
measures. Second, since Sepsis-3 based surveillance 
criteria do not require four days of antimicrobial treat-
ment, but two doses, feedback on patients that have 
developed sepsis can be presented to clinicians early in 
the treatment course. This facilitates optimisation of 
care beyond the very initial treatment phase, such as 
better source control, adequate diagnostics, optimised 
antimicrobial treatment, infectious diseases specialist 
consultation and targeted rehabilitation, all of which 
have the potential to improve patient outcomes.44 45 In 
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addition, 9% of patients fulfilling the Sepsis-3 clinical 
criteria did not have an infection, and 32% had only 
a possible infection, indicating the possibility to use 
this type of surveillance system as part of an antimi-
crobial stewardship programme, to balance the empir-
ical broad spectrum antimicrobial treatment imposed 
by guidelines such as the Surviving Sepsis Campaign 
Bundle.46–48
Strength and limitations
A strength of our study is the use of a large clinical 
dataset representative of the population in a defined 
catchment area. This is, to our knowledge the first 
report of a sepsis surveillance system using the Sepsis-3 
clinical criteria as case- definition, which overlaps 
better with other standards used for early sepsis recog-
nition. This enables the integration of surveillance data 
in the direct clinical care of individual patients which 
can encourage clinicians to use the data, as opposed to 
implementing criteria developed exclusively for retro-
spective surveillance and thus risking to disconnect 
surveillance from the everyday clinical work. When 
developing and validating the algorithm, we used a 
duplicate of the EHR system, to ensure that our model 
can be implemented using real- time patient data. We 
could follow each subject over time and were not 
limited to data from the current hospital admission. 
This improves proper calculation of baseline organ 
dysfunction, which has been a limitation in previous 
methods.14 Furthermore, we performed medical 
record review, showing that a rule- based surveillance 
algorithm performed well in non- ICU wards where 
data is usually of lower resolution and quality. This 
demonstrates that automated sepsis surveillance using 
the Sepsis-3 clinical criteria can be done without the 
need for complex computational methods such as text 
mining of unstructured data in EHR notes.
Limitations of fully- automated surveillance systems 
include possible misclassification of sepsis since both 
the algorithm and validation with medical record 
review depends on correct and accessible data in the 
EHR system. Not all hospital admissions with suspected 
infection contained the measurements necessary to 
assess a complete SOFA score, leading to missing data. 
By definition in the Sepsis-3 clinical criteria, missing 
values of SOFA score components were assumed to be 
normal, which may have affected correct classification 
of organ dysfunction and sepsis. Even though our vali-
dation sample included hospital admissions with and 
without suspected infection, our reference standard 
was based on infections recognised by clinicians and 
we may have missed sepsis cases among patients where 
an infection passed unnoticed. Sepsis classification can 
be affected by updates and changes in the EHR system, 
as well as by differences in recordings and access of 
data between wards, which could have influenced 
our results. This may explain the decreased algorithm 
specificity and PPV when restricting analyses to only 
hospital admissions including an ICU admission, from 
where we did not have access to data on medications 
and vital parameters. Since we did not include patient 
risk- time while in ICUs or obstetrical wards, our results 
cannot be generalised to such settings and inference 
on the true sepsis incidence is uncertain and should 
be interpreted with caution. It is also possible that 
patients’ characteristics, such as organ dysfunction and 
source of infection, may be different for sepsis devel-
oping in these wards. Yet, in the ICU, documentation 
is usually both extensive and of good quality and a 
similar surveillance system has performed well in this 
setting.49 The algorithm also showed lower sensitivity 
for HO sepsis compared with CO sepsis. This was 
primarily due to organ dysfunction only mentioned in 
free text, which indicates that improved recording of 
oxygen therapy and vital parameters such as GCS could 
result in better algorithm performance in surveillance 
of HO sepsis. Moreover, an implemented surveillance 
system requires continuous maintenance and valida-
tion. Although we used an exact duplicate of the EHR 
system, our algorithm has not yet been implemented 
and also needs evaluation in a real- world scenario. 
Finally, the study was limited to a single centre and 
needs confirmation within different EHR systems in 
different hospitals.
Conclusion
Based on data from EHR, it is feasible to automatically 
monitor sepsis incidence with good validity compared 
with physician medical record review in non- intensive 
care wards using the Sepsis-3 clinical criteria as surveil-
lance definition. The algorithm exposed variations in 
hospital- onset sepsis incidence depending on ward 
type, which can be used to tailor infection prevention 
interventions and improve sepsis care.
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